Resmed Inc (RMD)
Australian Securities Exchange · Australia · prices in AUD · close of 27 Oct 2026
Key indicators
| Last close | AUD 35.50 |
|---|---|
| 52-week range | 25.50 – 40.19 |
| Return, 1 month / 3 months | +12.4% / +27.2% |
| Return, 1 year / 3 years | −10.1% / +69.3% |
| Trend | Uptrend |
| RSI (14) | 73 |
| Volatility (1 year) | 29.8% |
| Worst drawdown (1 year) | -34.1% |
| Average daily value traded | 46.79M AUD |
| Dividend yield | 1.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
ResMed designs and manufactures devices and masks used to treat sleep-disordered breathing, including continuous positive airway pressure machines and the masks that go with them. It also makes ventilators and provides software that helps home medical equipment providers manage patients and their care. Its customers include clinicians, home care providers and patients in many countries, and the company is based in San Diego, California, with operations and sales around the world.
On this site Resmed Inc appears as a stock on the Australian Securities Exchange (Australia), code RMD, with prices in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Resmed Inc (RMD) trades on the Australian Securities Exchange in Australia. It last closed at AUD 35.50 on 27 October 2026.
Its price-based Market X-Ray is 81 out of 100 (a strong price profile), ranking 99 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 10.1% and over the last three months it rose 27.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 85 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 12.0% | ||
| From 52-week high | -11.1% | ||
| Momentum | 76 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 27.2% | ||
| 6-month return | 17.2% | ||
| 12-month return, skipping the last month | -20.1% | ||
| Stability (higher is calmer) | 82 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 29.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.1% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 46.79M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 51 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.4% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +3.8% |
|---|---|
| 1 month | +12.4% |
| 3 months | +27.2% |
| 6 months | +17.2% |
| 1 year | −10.1% |
| 3 years | +69.3% |
| 5 years | +2.7% |
Signals
| 50-day / 200-day average | 32.44 / 31.71 |
|---|---|
| Golden / death cross (60 days) | Golden, 8 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.57 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 19 Aug 2026 | USD 0.0950 |
| 13 May 2026 | USD 0.0863 |
| 11 Feb 2026 | USD 0.0863 |
| 12 Nov 2025 | USD 0.0863 |
| 13 Aug 2025 | USD 0.0863 |
| 7 May 2025 | USD 0.0763 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.